Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.
غير مصنف

CRISPR therapy for high cholesterol shows promise in early trial



A one-time, CRISPR-based gene therapy lowered people’s levels of “bad” cholesterol in a small trial, the treatment’s maker announced. While the new therapy shows promise, it still has a long way to go before it can be approved for use in patients.

The gene therapy, called VERVE-101, reduced the levels of low-density lipoprotein (LDL) cholesterol in the blood of people with familial hypercholesterolemia (FH), an inherited condition that boosts their LDL levels and their risk of heart disease, according to a statement from Massachusetts-based biotech company Verve Therapeutics, which makes the treatment.

اترك تعليقاً

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *

زر الذهاب إلى الأعلى